Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026)

“The trend is your friend, until it bends,” Ed Seykota (1995)

“Opportunity always knocks at the least opportune moment.” — Murphy’s Law

This is our continuing series where we apply a systematic/factor-based lens to the thematic investment landscape, focusing on fund exposures to common risk factors such as growth, value, momentum, quality, and volatility. Rather than judging a theme on narrative or recent performance alone, this systematic lens helps identify where investor sentiment may be building or recovering and the underlying risks expected to contribute to future volatility. Below, we review the broader factor backdrop across U.S. equities, then turn to this month’s Top Trending Themes (by Bloomberg Momentum factor), highlighting the Global X Genomics and Biotechnology ETF (GNOM), and the Most Out-of-Favor themes, highlighting the Global X U.S. Natural Gas ETF (LNGX).

For the month ending 9/30/2026, sentiment-based factors (Momentum, Estimate Revisions style factors) led Bloomberg U.S. equity universe factor performance, snapping back from underperformance over the prior two months. Fundamental factors (Dividend Yield, Growth, Quality, and Value) meaningfully underperformed as did Low Volatility, which significantly lagged the other factors on a trailing 1-year basis ending 9/30/2026. U.S. stocks experienced acute narrow breadth (% of stocks or factors outperforming the broader market) as the median stock in the S&P 500 Index fell 6% while the overall index only dropped 0.45% for the month ending 9/30/2026. The S&P Information Technology and Communication Services sectors were the only two major sectors to outperform in September, returning 4.5% and 4.3%, respectively, while all the other major sectors were negative for the month.

Trailing three-month performance reflects this environment of factor churn, witnessed by this year’s fluctuation of the Momentum factor from factor leader to factor laggard, as Momentum had previously experienced a sharp unwind between late June through late August. Yet, despite this sharp underperformance in early part of the third quarter, Momentum continued to lead all major factors year-to-date (YTD) through 9/30/2026. Overall market leadership remained concentrated in equity themes linked to advancements in Artificial Intelligence (AI) design and delivery, which may also influence how Momentum as a factor performs over the intermediate term.1

We continue to believe the fundamental backdrop for pro-cyclical leadership remains intact (see the Global X 2026 Mid-Year Outlook). As much as we are encouraged by the recovery in Momentum, we are mindful of the lack of factor breadth, particularly among fundamental-based factors where both growth and value performed poorly in September. If the narrowness in equity leadership persists, then further market advances may be built on a shrinking foundation. This could leave the broader market vulnerable to a major pullback, especially if the upcoming earnings season fails to meet expectations.

Note: all factors referenced in this article are defined by Bloomberg unless stated otherwise.

Through the Systematic Lens: Thematic Equity:  Factor Landscape (October 2026) Table 1

Key Takeaways

  • Following September’s recovery, Momentum continued to dominate U.S. equity factor leadership, as overall market leadership has grown increasingly concentrated in AI-technology focused companies. One may consider taking at least a neutral stance on Momentum, with an eye toward oversold themes whose growth fundamentals remain intact.
  • AI-adjacent computing, metals producers, genomics, and energy producers/distributors comprise our Top Trending Themes; we highlight the Global X Genomics & Biotechnology ETF (GNOM).
  • Genomics, food technology, energy producers, and dividend/cash-flow factors remain our most Out-of-Favor Themes (those that have lagged the broader market over the past four to five years) with genomics and conventional energy producers showing signs of recovery based on recent Momentum; we highlight the Global X US Natural Gas ETF (LNGX).
Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026) Chart 2

Among the Top Trending Themes, AI-adjacent and precious metal producers may benefit from positive growth factor exposure, while energy producers/distributors may benefit from positive value factor exposure.

As of 9/30/2026, we observe four thematic categories comprising the Top Trending list, as measured by the Bloomberg Momentum Factor. These themes have enjoyed positive pricing trends, signaling strong investor demand.

  1. Artificial Intelligence (AI)-Adjacent themes representing computing bottlenecks such as AI semiconductors/quantum (CHPX), along with critical inputs needed for capital spending on infrastructure / advanced devices such as copper miners (COPX). These themes trade at slight premium valuations (moderately negative Value exposure), but whose financial profiles are turning more stable (moderately positive Quality exposure). We believe the structural growth narrative remains intact given the strong AI and broader infrastructure capital expenditure cycle.
  2. Precious metals mining and/or exploration themes, such as AUAU, GOEX, SIL, benefited from the late 2025/early 2026 run-up in precious metals prices (primarily gold and silver) before correcting later in the year. The precious metals complex may face headwinds if heightened inflation expectations continue to warrant a hawkish monetary policy path for the Federal Reserve. Still, strong earnings growth (positive Growth exposure), improving financial metrics (positive Quality exposure) and reasonable valuations may help buffer further pressures on hard assets stemming from higher inflation-adjusted (real) interest rates and tighter monetary policies.
  3. Energy Producers (GXPE, LNGX) and Energy Distributors/Delivery (MLPA, MLPX) have benefitted from conventional energy supply constraints, largely brought on by geopolitical events (Ukraine/Russia, Strait of Hormuz Conflict) which disrupted global oil supply routes. Themes tied to conventional energy, whether upstream production or mid-stream distribution/delivery, are trading at less expensive valuations than the broader market, as investors likely expect the bump from higher commodity prices to near-term earnings growth to eventually normalize to lower long-term trend levels.
  4. Genomics (GNOM) rounds out the list, with renewed interest driven by AI’s transformative potential for gene therapy, drug discovery, and personalized medicine; it also appears on the Long-Term Reversal list below as this theme appears to be recovering from long-term underperformance versus the broader market. We profile the genomics theme (GNOM) as this month’s Top Trending Theme in Focus

This month we apply a factor lens to the Global X Genomics & Biotechnology ETF (GNOM). Here is the summary of the structural thesis:

  • Genomics and biotech are entering a multi-decade growth phase driven by platform breakthroughs, AI-driven R&D productivity, and demographic demand. Gene editing has moved into approved medicine, with CRISPR therapies cleared by the FDA, next-generation approaches advancing in the clinic, and the FDA streamlining pathways for personalized treatments.2,3 AI is cutting drug discovery cost and time from roughly $2-3 billion and 10-15 years, and cheap whole genome sequencing (approaching $500) is enabling population-scale precision medicine.4 Heightened demand may be driven by an aging population (the 60+ cohort doubling by 2050), expanding modalities such as mRNA, ADCs, cell and gene therapy, radiopharmaceuticals, and protein degraders, and pharmaceutical-focused capital deployed through M&A and partnerships.5,6

The charts below examine the fund’s current factor exposure and fundamental/pricing trends.

  • Market sentiment (Momentum) has significantly improved as the theme appears to be bottoming from a long-term downward trend (Long-Term Reversal). Recent news tied to advancements in personalized cancer vaccine treatments and AI model training likely serve as the catalysts for the turnaround in sentiment.7,8
  • Commensurate with the improvement in sentiment, the fund is also exhibiting improving Growth and Quality factor readings as well as lower Volatility versus its trailing five-year history.
Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026) Chart 3

GNOM has positive exposure to Growth and Momentum while exhibiting lower Volatility versus its 5-year history.

  • Estimated earnings for the underlying constituents of the Solactive Genomics Index (the tracking index for GNOM) have improved, though the underlying constituents of the index remained unprofitable. As of 9/30/26, its forward price/sales ratio has improved from the trough levels seen over the past two years, reflecting improving prospects, and room to grow into that valuation should these advancements in gene therapy reach commercialization.
Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026) Chart 4

Forward EPS for the Solactive Genomics Index has improved despite constituents having ongoing operating losses, while the Price/Sales ratio for the index has slowly expanded.

  • After troughing towards the end of April, the fund has recovered, sitting comfortably above its 200 moving day average as of 9/30/2026. The fund is neither overbought nor oversold on a short-term basis (as indicated by the 14-Day RSI through 9/30/2026), and the fund could see trend-following investors drive “buy-the-dip” demand on near-term pullbacks should the underlying fundamentals hold.
  • Overall, the genomics and biotechnology theme has benefited from a combination of positive price trends and strong growth catalysts
Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026) Chart 5

Price was above intermediate support (200-Day Moving Average); the RSI suggests the fund is neither overbought nor oversold as of 9/30/2026.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month- or quarter-end is available here.

Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026) Chart 6

Genomics and energy producers appear to be recovering from long-term underperformance (Long-Term Reversal) based on recent positive Momentum.

This month’s Top Out-of-Favor list, as measured by the Bloomberg Long-Term Reversal Factor, spans five categories. Many of the underlying securities held in these themes have underperformed over the past five years as investors moved on from the promising growth potential they once exhibited, though several are now showing signs of recovery.

  • Natural Gas Energy Producers (LNGX) remains out of favor as the natural gas market has lagged the recent advances seen across other conventional energy sources, such as oil and coal. However, as mentioned above, themes tied to conventional energy, whether upstream production or mid-stream distribution/delivery, are trending higher and trading at less expensive valuations (Value) than the broader market. We profile the U.S. natural gas theme (LNGX) as this month’s Out-of-Favor Theme in Focus.
  • The genomics and biotechnology theme (GNOM) has long been out of favor but is starting to see renewed interest as AI advances gene therapy and drug discovery. Earlier, we highlighted GNOM as the Top Trending Theme in Focus.
  • Alternative energy inputs/processing such as Hydrogen (HYDR), are showing some signs of consolidating as the growth outlook improves (Growth).
  • Defensive-oriented dividend payers (DIV, QDIV, SRET), free cash flow generators (FLOW), and our multi-factor ETF (AUSF) remained out of favor amid strong “risk-on” appetite and an optimistic earnings-growth outlook. A shift away from pro-cyclical leadership would likely be the catalyst for a turnaround, and low valuations (Value) may offer support for patient investors.
  • Food-innovation and agricultural tech theme (KROP) remained out of favor as earnings normalized from the post-Russia/Ukraine hypergrowth period and tracked lower grain and soybean prices. We view the theme as attractively valued but in need of a sustained growth catalyst.

Out-of-Favor Theme in Focus: Global X Natural Gas ETF (LNGX)

In this section, we’re applying a factor lens to the Global X Natural Gas ETF (LNGX). The long-term thesis is summarized here:

  • The structural bull case for U.S. natural gas producers and liquified natural gas (LNG) companies rests on a convergence of durable, multi-year demand catalysts. U.S. LNG feedgas demand is projected to more than double to 29.7 billion cubic feet/day (bcf/d) between 2024 and 2030, creating an average supply deficit of 0.6 bcf/d over that period.9 Peak LNG export volumes are projected to exceed 25 bcf/d by 2028 as new capacity additions ramp, with data center build-outs expected to cause a 7.7 gigawatt (GW) increase in average power demand in 2026 alone.10 Global LNG demand is forecast to grow at 5.8% per annum from 2025–2030, driven primarily by emerging Asia, with Chinese LNG demand projected to rise 65% during this period.11 Geopolitical disruptions, including damage to Qatari LNG facilities taking approximately 50 million tonnes per year offline, could take years to repair, further accelerating demand for U.S. supply.12

Here we review LNGX’s factor exposure and fundamental / pricing trends. Funds with under one year of history (like LNGX) are only shown with current factor exposures:

  • Excess production leading to oversupply and questionable capital allocation decisions have weighed on this theme, helping to explain the long-term underperformance.13
  • The geopolitical environment has contributed to the disruption of global energy supplies, including LNG as well as surging AI data center power demand are now fueling a recovery in natural gas producers and distributors, reflected in LNGX’s positive Momentum reading.
  • LNGX’s Growth factor exposure remains negative as earnings growth has stalled (see below) while waiting for the demand environment to turn more favorable for the sector; however, the theme continues to trade at attractive valuations (Value).
  • The theme is also exhibiting lower volatility (Volatility, 30-Day Idiosyncratic Return), possibly reflecting the steady environment of natural gas pricing and demand.
Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026) Chart 7

LNGX has exhibited less volatility (Volatility, 30-Day Idiosyncratic Return) while Value remains attractive but the Growth outlook is likely contingent on demand catalysts to be realized.

  • Estimated earnings for the underlying constituents of the Global X U.S. Natural Gas Index (the tracking index for LNGX) have slowly improved since inception of the index, likely helped by the supply constraints from the aftermath of geopolitical conflicts. As of 9/30/26, its forward price/earnings multiple has compressed slightly as projected earnings have risen, possibly indicating investor expectations of a normalized path of earnings following the spike in energy prices in response to the Strait of Hormuz conflict.
Through the Systematic Lens: Thematic Equity: Factor Landscape (October 2026) Chart 8

Forward EPS for the Solactive U.S. Natural Gas Index has improved following the Strait of Hormuz conflict, while the Price/Earnings ratio has declined, improving the valuation profile.

  • After rallying sharply through the height of the Strat of Hormuz conflict (around the end of March), LNGX has traded in a tight range, having just broken its 200 moving day average (as of 9/30/2026). The recent selling pressures (as indicated by the 14-Day RSI through 9/30/2026) appear to be overextended as natural gas prices have pulled back from their recent highs.
  • The natural gas theme is enjoying improving sentiment although the growth outlook appears to in a holding pattern until demand catalysts start to materialize. LNGX potentially offers high operating leverage to greater demand posed by energy-hungry data centers and from energy importing countries across Asia and Europe.
Through the Systematic Lens: Thematic Equity:  Factor Landscape (October 2026) Chart 9

LNGX’s price has mostly trended higher but just recently dropped below its 200-day moving average. The RSI points to oversold conditions.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month- or quarter-end is available here.

Conclusion

We believe a practical starting point for building a thematic equity portfolio is a core group of funds spanning a broad cross-section of themes, with opportunistic allocations to out-of-favor or underappreciated themes.

  1. For themes with positive price trends, consider AI-adjacent themes (CHPX), commodity producers (AUAU, COPX, GOEX, GXPE, MLPA, MLPX, and SIL), and genomics (GNOM). Keep in mind, precious metal miners and/or explorers (such as AUAU, GOEX, SIL) could remain pressured by inflation and interest rate uncertainty but could see better entry points if rates decline. We highlighted GNOM as a Top Trending Theme following July’s tech sell-off.
  2. For out-of-favor themes showing recent recovery, consider conventional and alternative energy (GXPE, HYDR, LNGX) and life sciences (GNOM). Defensive, dividend- and cashflow-focused themes (AUSF, DIV, QDIV, FLOW, SRET) and food innovation/ agriculture tech (KROP) remained out of favor but could turn if market sentiment shifts defensive. We highlighted LNGX as a Top Out-of-Favor Theme given its improving sentiment and attractive valuations.

AUAU – Global X Gold Miners ETF

AUSF – Global X AI Adaptive U.S. Factor ETF

CHPX – Global X AI Semiconductor & Quantum ETF

COPX – Global X Copper Miners ETF

DIV – Global X SuperDividend® U.S. ETF

FLOW – Global X U.S. Cash Flow Kings 100 ETF

GNOM – Global X Genomics & Biotechnology ETF

GOEX – Global X Gold Explorers ETF

GXPE – Global X PureCap℠ MSCI Energy ETF

HYDR – Global X Hydrogen ETF

KROP – Global X AgTech & Food Innovation ETF

LNGX – Global X U.S. Natural Gas ETF

MLPA – Global X MLP ETF

MLPX – Global X MLP & Infrastructure ETF

QDIV – Global X S&P 500® Quality Dividend ETF

SIL – Global X Silver Miners ETF

SRET – Global X SuperDividend® REIT ETF

Click the fund name above to view current performance and holdings. Holdings are subject to change. Current and future holdings are subject to risk.